(AGA) on the management of mild-to-moderate ulcerative colitis (UC). The guideline was
developed by the AGA Institute's Clinical Guidelines Committee and approved by the AGA …

Most patients with ulcerative colitis (UC) have mild-to-moderate disease activity, with low risk
of colectomy, and are managed by primary care physicians or gastroenterologists. Optimal …

A subset of patients with ulcerative colitis (UC) present with, or progress to, moderate to
severe disease activity. These patients are at high risk for colectomy, hospitalization …

Background & Aims The medical management of ulcerative colitis (UC) has improved
through the development of new therapies and novel approaches that optimize existing …

AGA (American Gastroenterological Association), 5-ASA (5-aminosalicylate), ASUC (acute
severe ulcerative colitis), CI (confidence interval), FDA (US Food and Drug Administration) …

11.1. General The treatment strategy for ulcerative colitis [UC] is mainly based on the
severity, distribution [proctitis, left-sided, extensive] 1 and pattern of disease. The latter …

Ulcerative colitis (UC) is an idiopathic inflammatory disorder. These guidelines indicate the
preferred approach to the management of adults with UC and represent the official practice …

Ulcerative colitis (UC) is a chronic idiopathic inflammatory disorder that involves any part of
the colon starting in the rectum in a continuous fashion presenting typically with symptoms …

Background: Patient care in ulcerative colitis (UC) remains challenging despite an array of
established treatment options and emerging new therapies. The management of UC therapy …

Ulcerative colitis (UC) is a chronic disease featuring recurrent inflammation of the colonic
mucosa. The goal of medical treatment is to rapidly induce a steroid-free remission while at …